Biomarkers of myocardial fibrosis and their genetic regulation in patients with heart failure
Open Access
- 18 November 2020
- journal article
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 25 (10), 3933
- https://doi.org/10.15829/1560-4071-2020-3933
Abstract
Currently, the development of chronic heart failure (CHF) is considered from the perspective of pathological structural remodeling of myocardium and fibrosis. Despite the widespread use of molecular genetic markers in clinical practice, only a small number of them are used to evaluate remodeling processes, as well as to predict potential complications associated with heart failure (HF). In addition, the relationship between many biomarkers with instrumental and histological confirmation of myocardial fibrosis has not yet been determined. Myocardial fibrosis remains quite debatable and controversial subject, which actualizes the further study of this direction. The discovery of pathogenetic and diagnostic markers of myocardial fibrosis could contribute to the development of targeted therapy. Of particular interest is the search for possible pathogenetic markers, since this is relevant for clinical practice.Keywords
This publication has 46 references indexed in Scilit:
- World Heart Federation Roadmap for Heart FailureCVD Prevention and Control, 2019
- Fibroblasts in the Infarcted, Remodeling, and Failing HeartJACC: Basic To Translational Science, 2019
- Connective Tissue Growth Factor Inhibition Enhances Cardiac Repair and Limits Fibrosis After Myocardial InfarctionJACC: Basic To Translational Science, 2019
- Association of Elevated NT-proBNP With Myocardial Fibrosis in the Multi-Ethnic Study of Atherosclerosis (MESA)Journal of Invasive Cardiology, 2017
- Metalloproteinases in atherosclerosisEuropean Journal of Pharmacology, 2017
- Cardiac fibrosis in myocardial infarction—from repair and remodeling to regenerationCell and tissue research, 2016
- Serum Matrix Metalloproteinases as Quantitative Biomarkers for Myocardial Fibrosis and Sudden Cardiac Death Risk Stratification in Patients With Hypertrophic CardiomyopathyJournal of Cardiac Failure, 2016
- Circulating Biomarkers of Myocardial FibrosisJournal of Invasive Cardiology, 2015
- Regulation of Connective Tissue Growth Factor Gene Expression and Fibrosis in Human Heart FailureJournal of Cardiac Failure, 2013
- Type I Collagen Cleavage Is Essential for Effective Fibrotic Repair after Myocardial InfarctionThe American Journal of Pathology, 2011